News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Biopheresis Technologies, Inc. Awarded Grant 'Biochance Plus-3' For The Development Of Its New Cancer Treatment Approach


11/10/2006 11:39:39 AM

HEIDELBERG, Germany--(BUSINESS WIRE)--BioPheresis GmbH has received a 2-year grant from the federal government for about 0.5 million Euros, to accelerate and expand the current and further work on a new cancer treatment with the company’s OncoSorb® column.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES